Results 121 to 130 of about 1,622,247 (397)
ELECTROPHYSIOLOGY: Temporary cardiac pacing [PDF]
Heart, 2000 Paul Zoll first applied clinically effective temporary cardiac pacing in 1952 using a pulsating current applied through two electrodes attached via hypodermic needles to the chest wall in two patients with ventricular standstill.1 Although this technique was uncomfortable for the patients it was effective for 25 minutes in one patient and nearly five ...
openaire +3 more sources
Cardiac Arrest - Electrical Resuscitation and Pacing of the Heart [PDF]
, 1963 Aubrey Leatham
openalex +1 more source
Ventricular Tachycardia in the Absence of Structural Heart Disease [PDF]
, 2005 In up to 10% of patients who present with ventricular tachycardia (VT), obvious structural heart disease is not identified. In such patients, causes of ventricular arrhythmia include right ventricular outflow tract (RVOT) VT, extrasystoles, idiopathic ...
Appleton, Christopher P +4 more
core +1 more source
Interventional therapies for chronic heart failure: An overview of recent developments
ESC Heart Failure, Volume 12, Issue 2, Page 1081-1094, April 2025.Abstract Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the ...
Bingchen Guo +7 more
wiley +1 more source
How to diagnose and manage patients with cardiac implantable electronic device infections
Journal of Arrhythmia, 2013 Over the last two decades, there has been a surge in the number of Cardiac Implantable Electronic Device (CIED) implantation. These devices improve the quality of life and survival among certain cardiac patients.
Khaldoun G. Tarakji, Bruce L. Wilkoff
doaj +1 more source
A new era of physiologic cardiac pacing. [PDF]
Eur Heart J Suppl, 2023 Burri H, Vijayaraman P.
europepmc +1 more source
Considerations for drug trials in hypertrophic cardiomyopathy
ESC Heart Failure, Volume 12, Issue 2, Page 1095-1112, April 2025.Abstract Hypertrophic cardiomyopathy (HCM) is a heterogeneous condition with potentially serious manifestations. Management has traditionally comprised therapies to palliate symptoms and implantable cardioverter‐defibrillators to prevent sudden cardiac death. The need for disease‐modifying therapies has been recognized for decades.
John P. Farrant +17 more
wiley +1 more source
Electroanatomic mapping reconstruction with photogrammetry across different mapping systems
Frontiers in ImagingBackgroundAutomatic digital photogrammetry produces digital reproductions of objects using photographs. The aim of this study is to analyze feasibility of photogrammetry for electroanatomic map (EAM) reconstruction from different mapping systems ...
Giacomo Talevi +15 more
doaj +1 more source
Role of Implantable Cardioverter Defibrillators in the Treatment of Hypertrophic Cardiomyopathy [PDF]
, 2005 Hypertrophic cardiomyopathy (HCM) is an important cardiovascular disease with sudden cardiac death as the most devastating presentation. Implantable cardioverter defibrillators (ICD) are the optimal therapy for prevention of sudden death from ventricular
Francis, Johnson +2 more
core +1 more source